Study of Labour Epidural Analgesia for the Parturient with Heart Disease

Dr. Jyoti kurtakoti; Dr. Rahul kore; Dr. Pushpa Agrawal; Dr. Aishwarya; Dr. Arundhati Jayanandan; Dr. Ameer Norat; Dr. Pravin Jadhav; Dr. Sachin Swami1

1

Publication Date: 2023/04/21

Abstract: Management of pregnant women with heart disease remains challenging due to the advancement of innovations in cardiac surgery and correction of complex cardiac anomalies, and more recently, with the successful performance of heart transplants, cardiac diseases are not only likely to coexist with pregnancy, but will also increase in frequency over the years to come. In developing countries with a higher prevalence of rheumatic fever, cardiac disease may complicate as many as 5.9% of pregnancies with a high incidence of maternal death. A prospective clinical study was conducted in Department of Anaesthesia, at a tertiary care hospital and medical college for period of September 2019 to October 2021. 50 pregnant women who received epidural analgesia were enrolled in the study. In our study we used low dose 0.0625% of bupivacaine (10 ml) with 2mcg/ml of Fentanyl as bolus and top up (5 ml of same concentration) is effective with haemodynamic stability and without any side effects.

Keywords: Parturient, Heart Disease, Labour Epidural Analgesia.

DOI: https://doi.org/10.5281/zenodo.7851434

PDF: https://ijirst.demo4.arinfotech.co/assets/upload/files/IJISRT23APR574.pdf

REFERENCES

No References Available